The use of citrate/theophylline/adenosine/dipyridamol (CTAD)-blood in coagulation and haematology;Verwendung von zitrat/theophyllin/adenosin/dipyridamol (CTAD)-blut in hämostaseologie und hämatologie

LaboratoriumsMedizin

Volumn 26, Issue 5-6, 2002, Pages 296-306

  Töpfer, Gottfried ^a   Zawta, B ^b   Hornig, F ^a   Sauer, K ^a   Friedel, Gisela ^a  

^a Stadtisches Klinikum Gorlitz gGmbH   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

aPTT; Automatic differential blood count; Citrate blood; CTAD blood; Differential blood count; EDTA blood; Global tests in coagulation; Heparin determination; Heparin influence; Platelet factor 4; Stability of plasma; Thrombin time

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; CITRIC ACID; COLLAGEN; DIPYRIDAMOLE; EDETIC ACID; HEPARIN; RISTOCETIN; THEOPHYLLINE; THROMBOCYTE FACTOR 4;

ACCURACY; ARTICLE; BLOOD CELL; BLOOD CELL COUNT; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD STORAGE; DEVICE; HEMATOLOGY; HEPARINIZATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; NEUTROPHIL; PARAMECIUM; PARTIAL THROMBOPLASTIN TIME; PLASMA; THROMBIN TIME; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE VOLUME;

EID: 0036302050     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0477.2002.02063.x     Document Type: Article

References (18)

1. Einfluss von 2 citratkonzentrationen auf die ergebnisse von gerinnungsprüfgrößen und auf die plasmastabilität in abhängigkeit von den reagenseigenschaften
2. Evaluation of an amidolytic heparin assay method. Increased sensitivity by adding purified antithrombin III
3. Heparin inactivation during blood storage: ITS prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole - C.T.A.D Mixture
4. Monitoring heparin therapy by the activated partial thromboplastin time - The effect of pre-analytical conditions
5. Preanalytical recommendations of the "groupe d'etude sur l'hémostase et la thrombose" (GEHT) for venous blood testing in hemostasis laboratories
6. Preanalytical requirement for platelet activation tests
7. Citrate-theophyline-adenine-dipyridamole buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation
8. Preanalytical requirements for flow cytometric evaluation of platelet activation: Choice of anticoagulant
9. The use of hirudin as universal anticoagulant in haematology, clinical chemistry and blood grouping
10. Die beeinflussung von gerinnungstesten durch rekombinantes hirudin
11. Inadequate quality of a blood collection tube containing an anticoagulant/platelet inhibitor mixture
12. Modulation of blood cell activation by four commonly used anticoagulants
13. The effect of various anticoagulant/antiplatelet mixtures on determination of plasminogen activator inhibitor, platelet proteins and hemostasis parameters
14. Inhibition of in vitro platelet aggregation and release and fibrinolysis
15. Influence of storage time and temperature on haematological measurands using a sysmex NE 8000 analyser
16. Differentialblutbilder im EDTA-Blut. Fehlermöglichkeiten und grenzen
17. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole
18. Flow cytometric method for simultaneous assay of foetal haemoglobin containing red cells, reticulocytes and foetal haemoglobin containing reticulocytes